Diltiazem reverses tissue Doppler velocity abnormalities in pre-clinical hypertrophic cardiomyopathy

Heart Lung and Circulation

Volumn 13, Issue 1, 2004, Pages 39-40

  McTaggart, Donald R ^a  

^a LAUNCESTON GENERAL HOSPITAL   (Australia)

Author keywords

Cardiomyopathy; Echocardiography; Genetics; Hypertrophic; Treatment

Indexed keywords

CARDIAC MYOSIN; DILTIAZEM; PROTEIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIASTOLE; DISEASE CARRIER; DOPPLER ECHOCARDIOGRAPHY; DRUG DOSE REGIMEN; DRUG MECHANISM; ELECTROCARDIOGRAPHY; FEMALE; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; PROTEIN BINDING; SYSTOLE; TREATMENT OUTCOME;

EID: 21344464498     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2004.02.002     Document Type: Article

References (7)

1. McTaggart DR. Tissue Doppler imaging in hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart Lung Circ 11(2);2002.
2. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-30.
3. Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, et al. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 2002;105:2992-7.
4. Peverill RE, Bain JL, Moir S, Mottram PM, Jankelowitz C, Donelan L, et al. Factors influencing long axis contraction and relaxation velocities in normal adults. Abstracts of Australian and New Zealand Cardiac Society Annual Meeting; 2003.
5. Alam M, Wardell J, Andersson E, Samad BA, Nordlander R. Characteristics of mitral and tricuspid annular velocities as determined by pulse wave tissue Doppler imaging in healthy subjects. J Am Soc Echocardiogr 1999;12:618-28.
6. Semsarian C, Ahmad I, Giewat M, Georgakopoulos D, Schmitt JP, McConnell BK, et al. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J Clin Invest 109(2002):1013-20.
7. Yu B, French JA, Jeremy RW, French P, McTaggart DR, Nicholson MR, et al. Counselling issues in familial hypertrophic cardiomyopathy. J Med Genet 1998;35:183-8.